D Nappi
Overview
Explore the profile of D Nappi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
25
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martino E, Palmieri S, Galli M, Derudas D, Mina R, Della Pepa R, et al.
ESMO Open
. 2025 Jan;
10(2):104084.
PMID: 39778329
Background: Daratumumab-refractory multiple myeloma (Dara-R MM) presents a significant treatment challenge. This study aimed to evaluate the efficacy and survival outcomes of elotuzumab, pomalidomide, and dexamethasone (EloPd) in a large,...
2.
Renshaw A, Cronin J, Minter L, Nappi D, Whitman T, Jiroutek M, et al.
Am J Clin Pathol
. 1999 Apr;
111(4):517-22.
PMID: 10191772
Rapid (30-second) prescreening of cervicovaginal smears can be used to detect false-negative cases and determine the false-negative rate of primary screening, but the performance characteristics have not been evaluated fully....
3.
Renshaw A, Comiter C, Nappi D, Granter S
Cancer
. 1998 Jul;
84(3):148-52.
PMID: 9678728
Background: Effusions in patients with renal cell carcinoma are rare; the clinicopathologic features of these patients have not been described fully. Methods: All effusions from patients with renal cell carcinoma...
4.
Renshaw A, Nappi D, Sugarbaker D, Swanson S
Cancer
. 1998 Jan;
81(6):365-72.
PMID: 9438462
Background: Effusions in patients with esophageal carcinoma have only been reported rarely, and the cytologic findings in these specimens have not been well described. Methods: The authors reviewed 70 effusion...
5.
Renshaw A, Nappi D, Swanson S, Sugarbaker D
Am J Clin Pathol
. 1997 Feb;
107(2):206-10.
PMID: 9024069
Extrapleural pneumonectomy to treat malignant mesothelioma may offer a significant survival advantage for selected patients. The role of effusion cytology in these patients has not been previously examined. To evaluate...
6.
Renshaw A, Nappi D, Cibas E
Diagn Cytopathol
. 1996 Aug;
15(2):103-7.
PMID: 8872430
Malignant pleural effusions due to prostatic carcinoma are rare. We examined the cytologic and clinical presentations of 14 malignant pleural effusions caused by prostate cancer. These cases represented 2.3% of...
7.
Renshaw A, Nappi D, Weinberg D
Acta Cytol
. 1996 Jul;
40(4):676-82.
PMID: 8693885
Objective: To assess the diagnostic criteria for grade 1 papillary transitional cell carcinoma (TCC) in cystoscopically obtained urine. Study Design: We compared the sensitivity, specificity and positive predictive value of...